L

Lumos Diagnostics Holdings Ltd
ASX:LDX

Watchlist Manager
Lumos Diagnostics Holdings Ltd
ASX:LDX
Watchlist
Price: 0.029 AUD
Market Cap: 21.7m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

LDX doesn't have a meaningful market cap.

The Relative Value of one LDX stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.029 AUD, Lumos Diagnostics Holdings Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LDX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
64
vs Industry
70
Median 3Y
1
Median 5Y
1.1
Industry
2.3
Forward
0.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.8
Industry
22
Forward
-3.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-1.9
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.4
Industry
20
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
50
vs Industry
58
Median 3Y
1.4
Median 5Y
1.4
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
62
vs Industry
71
Median 3Y
1.1
Median 5Y
1.2
Industry
2.4
Forward
0.8
More Details
1.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.6
vs History
72
vs Industry
78
Median 3Y
1.8
Median 5Y
2.2
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.2
Industry
11.6
Forward
1.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.2
Industry
15.9
Forward
2.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-2.1
Industry
14.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-1.8
Industry
18
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
46
vs Industry
70
Median 3Y
0.7
Median 5Y
0.8
Industry
1.8
More Details

Multiples Across Competitors

LDX Competitors Multiples
Lumos Diagnostics Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Lumos Diagnostics Holdings Ltd
ASX:LDX
21.7m AUD 1 -2.8 -3.5 -3.5
CH
Alcon AG
SIX:ALC
34.4B CHF 4.3 38.3 17.6 33.3
JP
Hoya Corp
TSE:7741
6.2T JPY 7.2 30.8 19 22.7
DK
Coloplast A/S
CSE:COLO B
136.2B DKK 4.9 30 17.3 20.4
US
Align Technology Inc
NASDAQ:ALGN
14.2B USD 3.6 34.6 16.5 20.4
CH
Ypsomed Holding AG
SIX:YPSN
5.7B CHF 7.6 65 31.2 53.4
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 37.3 208.3 340.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.3B CNY 12 30.3 26.1 26.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.6B USD 3.7 22.1 10.2 11.7
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.5B USD 4 45.2 20.8 36.4
KR
HLB Inc
KOSDAQ:028300
6.8T KRW 91.6 -36.3 -64.4 -60.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Average EV/EBITDA: 40.8
Negative Multiple: -3.5 		N/A N/A
CH
Alcon AG
SIX:ALC
17.6
10%
1.8
JP
Hoya Corp
TSE:7741
19
9%
2.1
DK
Coloplast A/S
CSE:COLO B
17.3
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
16.5
15%
1.1
CH
Ypsomed Holding AG
SIX:YPSN
31.2
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
208.3
11%
18.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.1
18%
1.4
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.2
21%
0.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
20.8
12%
1.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -64.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
L
Lumos Diagnostics Holdings Ltd
ASX:LDX
Average EV/EBIT: 62.8
Negative Multiple: -3.5 		N/A N/A
CH
Alcon AG
SIX:ALC
33.3
25%
1.3
JP
Hoya Corp
TSE:7741
22.7
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.4
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
20.4
17%
1.2
CH
Ypsomed Holding AG
SIX:YPSN
53.4
N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
340.7
22%
15.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26.1
16%
1.6
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.7
22%
0.5
US
Merit Medical Systems Inc
NASDAQ:MMSI
36.4
28%
1.3
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -60.9 N/A N/A

See Also

Summary
LDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
LDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LDX stock valuation using valuation multiples.
Wall Street Estimates
LDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 268,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.